Eculizumab as a Rescue Therapy for Early Antibody-Mediated Rejection After Kidney Transplantation (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO1186; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "She received induction with Basiliximab, solumedrol, IVIG and was maintained on Prednisone, Envarsus and Mycophenolate Mofetil...She was treated with six doses of Eculizumab, six cycles of plasmapheresis/IVIG, and single dose of rituximab...Eculizumab has been reported as a rescue therapy in case reports and small series. Our case highlights the early detection of ABMR with abrupt DSA increase and the prompt use of eculizumab as an effective therapy to salvage the allograft."
Antibody-mediated Rejection • Diabetes • Metabolic Disorders • Transplantation
|
|
Pooja V. Patel; Shreeyukta Bhattarai; Jennifer Dailey; Basma Omar Merhi
|